Which age group is specifically recommended to receive the pneumococcal vaccine?

The recommendation for adults over 65 years of age to receive the pneumococcal vaccine is based on their increased susceptibility to pneumonia, which can lead to severe complications and higher mortality rates. As individuals age, their immune system may weaken, making it more difficult for them to fight infections. The pneumococcal vaccine helps protect against several strains of pneumococcal bacteria, which are common causes of pneumonia, meningitis, and bloodstream infections.

While the pneumococcal vaccine is also recommended for children under 5 years of age to protect them during a critical time of development, the specific focus on adults over 65 in this scenario highlights the significant impact of these infections on older populations. Vaccination in this age group is crucial for preventing morbidity and mortality associated with pneumococcal diseases. Therefore, the recommendation underscores a public health priority aimed at safeguarding the health of older adults who are at a higher risk.